开放、腹腔镜与机器人辅助肾部分切除术的功能与肿瘤学结局:中位5年随访的多中心配对比较
该多中心回顾性研究纳入2006—2012年接受肾部分切除术的1 308例患者,经1:1:1倾向评分匹配后每组122例,比较机器人辅助(RAPN)、腹腔镜(LPN)与开放(OPN)三种术式。中位随访约5年,三组局部复发、远处转移及肿瘤相关死亡无显著差异;RAPN与更低的慢性肾病(CKD)分期上调发生率及更高的5年无CKD生存率相关。
要点
- 三种术式5年肿瘤学结局(局部复发、远处转移、肿瘤死亡)无显著差异。
- RAPN的CKD分期上调发生率低于LPN(20.55% vs 32%)与OPN(20.5% vs 33.6%)。
- RAPN组5年无CKD生存率78.4%,高于LPN的58.8%与OPN的65.8%。
核心结论
- 在中位5年随访中,RAPN、LPN与OPN的局部复发、远处转移及肿瘤相关死亡率相似。
- 功能结局方面,RAPN较OPN和LPN与更低的CKD分期上调发生率相关。
研究设计与样本
- 多中心回顾性比较研究,纳入2006—2012年四家学术中心接受肾部分切除术的1 308例患者(RAPN 380例、LPN 206例、OPN 722例)。
- 采用1:1:1倾向评分匹配校正混杂因素,最终366例(每组122例)纳入分析,生存率用Kaplan-Meier法分析。
主要发现
- RAPN平均估计失血量显著低于LPN(P = 0.025)和OPN(P = 0.040)。
- LPN平均手术时间较RAPN(P = 0.001)和OPN(P = 0.001)更长,RAPN组住院时间更短(P = 0.008)。
- 三组局部复发率(P = 0.882)、远处转移率(P = 0.816)及肿瘤死亡(P = 0.779)无显著差异。
- RAPN的CKD分期上调发生率显著低于LPN(20.55% vs 32%;P = 0.035)和OPN(20.5% vs 33.6%;P = 0.038)。
- RAPN组5年无CKD生存率78.4%,显著高于LPN的58.8%和OPN的65.8%(log-rank P = 0.031)。
关键数值与推荐
- 中位随访时间:RAPN 60个月、LPN 59.8个月、OPN 64.1个月。
- 匹配后每组122例,共366例。
- CKD分期上调发生率:RAPN 20.55% vs LPN 32%(P = 0.035);RAPN 20.5% vs OPN 33.6%(P = 0.038)。
- 5年无CKD生存率:RAPN 78.4%、LPN 58.8%、OPN 65.8%(log-rank P = 0.031)。
临床怎么用
- 在需要保留肾功能的肾部分切除术中,RAPN可能有助于降低术后CKD分期上调风险。
- 三种术式肿瘤学结局相近,术式选择可综合功能保护、失血量、手术时间与住院时间等因素考虑。
局限性
- 为回顾性研究,存在选择偏倚可能,虽经倾向评分匹配校正混杂因素。
- 随访为中位约5年,长期肿瘤学与功能结局仍需更长时间验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare outcomes at a 5-year median follow-up among different partial nephrectomy (PN) approaches: robot-assisted (RAPN), laparoscopic (LPN) and open partial nephrectomy (OPN). PATIENTS AND METHODS: We retrospectively analysed 1 308 patients who underwent PN (RAPN, n = 380; LPN, n = 206; OPN, n = 722) between 2006 and 2012 at one of four academic centres. We performed 1:1:1 propensity-score-matching adjustment based on confounding variables among groups, and 366 patients (122 in each group) were included in the final analysis. Survival rates were analysed using the Kaplan-Meier method. RESULTS: The median follow-up periods were 60, 59.8 and 64.1 months for RAPN, LPN and OPN, respectively. In the matched groups, RAPN resulted in significantly lower mean estimated blood loss compared with LPN (P = 0.025) and OPN (P = 0.040), while LPN was associated with a longer mean operating time compared with RAPN (P = 0.001) and OPN (P = 0.001). The hospital stay was shorter in the RAPN group (P = 0.008). Regarding the oncological outcomes, there were no significant differences among the three groups in local recurrence rate (P = 0.882), distant metastasis rate (P = 0.816) or deaths from cancer (P = 0.779). At latest follow-up, the incidence of chronic kidney disease (CKD) upstaging was significantly lower in RAPN compared with LPN (20.55% vs 32%; P = 0.035) and OPN (20.5% vs 33.6%; P = 0.038). The 5-year CKD free-survival rate was significantly higher (78.4%) in the RAPN group compared with 58.8% and 65.8% in the LPN and OPN groups, respectively (log-rank P = 0.031). CONCLUSIONS: In the present study, RAPN, LPN and OPN had similar local recurrence, distant metastasis and cancer-related death rates at a 5-year median follow-up. In terms of functional outcomes, RAPN was associated with a lower incidence of CKD upstaging compared with OPN and LPN.
引用
- Chang KD, Abdel Raheem A, Kim KH, et al. Functional and oncological outcomes of open, laparoscopic and robot-assisted partial nephrectomy: a multicentre comparative matched-pair analyses with a median of 5 years' follow-up. BJU Int. 2018. PMID: 29645344. doi:10.1111/bju.14250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。